EP
CNMD icon

Edgestream Partners’s CONMED CNMD Stock Holding History

Edgestream Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
7,384
-51,120
-87% -$2.08M 0.01% 822
2025
Q4 		$2.38M Buy
+58,504
New +$2.55M 0.07% 487
2024
Q1 		– Sell
-7,942
Closed -$870K – 836
2023
Q4 		$870K Buy
+7,942
New +$821K 0.06% 476
2022
Q3 		– Sell
-14,714
Closed -$1.41M – 473
2022
Q2 		$1.41M Buy
14,714
+8,424
+134% +$1.01M 0.11% 264
2022
Q1 		$934K Buy
+6,290
New +$878K 0.07% 340
2021
Q3 		– Sell
-22,336
Closed -$3.07M – 504
2021
Q2 		$3.07M Buy
+22,336
New +$3.06M 0.18% 183

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Edgestream Partners's CNMD Position: Q1 2026 in Review

Edgestream Partners reduced its CONMED (CNMD) stake by 87% in Q1 2026, selling an estimated $2.08M and leaving 7,384 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #822.

Edgestream Partners first reported a position in CNMD in Q2 2021 and has held it in 6 quarters since. The position peaked at $3.07M in Q2 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Edgestream Partners held 7,384 shares of CONMED worth $261K as of Q1 2026.
  • Edgestream Partners sold 51,120 CONMED shares in Q1 2026, an estimated $2.08M.
  • CONMED made up 0.01% of Edgestream Partners's portfolio in Q1 2026, its #822 holding.
  • Edgestream Partners first reported a position in CONMED in Q2 2021 and has held it in 6 quarters since.
  • Edgestream Partners's CONMED position peaked at $3.07M in Q2 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.